DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ghavamzadeh A, Alimoghaddam K, Rostami S. et al
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
J Clin Oncol 2011;
29 (20) 2753-2757
We do not assume any responsibility for the contents of the web pages of other providers.